Client News

Apogenix AG – COVID-19: targeted treatment trial launched in Vienna

Adocia announces its financial calendar for 2021

Abivax to present at the 39th Annual J.P. Morgan Healthcare Conference ahead of major clinical milestones

Allecra Therapeutics and Shanghai Haini Pharmaceutical Announce Exclusive Licensing Agreement for Cefepime/enmetazobactam for Greater China

XPHYTO Therapeutics completes successful SARS-CoV-2 RT-PCR diagnostic test kit validation

4basebio AG – Update regarding the status of the settlement of the spin-off

Marinomed Biotech AG announces grant of European Patent covering the proprietary Marinosolv® technology to generate aqueous solutions from insoluble compounds

MagForce AG Successfully Completes Private Placement of New Shares

CENTOGENE GmbH: CENTOGENE and Alnylam Pharmaceuticals Launch a New Clinical Program Aimed at Revolutionizing the Diagnosis of Hereditary Transthyretin-Related Amyloidosis (“ATTRv”)

MagForce AG Announces Opening of New NanoTherm Treatment Center for Brain Tumor Patients at Mühlhausen Hufeland Clinic in Thuringia, Germany